Concord Biotech files a DRHP for an IPO with backing from Rare Enterprises and Quadria Capital

As a way to elevate cash by means of an Preliminary Public Providing (IPO), Harmony Biotech Restricted, one of many prime international builders and producers of particular fermentation-based APIs throughout immunosuppressants and oncology when it comes to market share in 2021, has filed its Draft Pink Herring Prospectus (DRHP) with the markets regulator, Securities and Change Board of India (SEBI).

The providing, which has a face worth of Re1 per fairness share, is a full supply on the market (OFS) by Helix Funding Holdings Pte. Restricted, totaling 20,925,652 fairness shares. The supply additionally permits certified workers to order a subscription.

The supply is being made by means of the guide constructing course of, wherein not lower than 15% of the supply should be made out there to non-institutional bidders, not lower than 35% of the supply should be made out there to retail particular person bidders, and no more than 50% of the supply should be allotted to certified institutional patrons.

In accordance with the F&S report’s DRHP, Harmony Biotech will maintain a market share of over 20% by quantity in 2021 for the recognized fermentation-based API merchandise dactinomycin, sirolimus, tacrolimus, mycophenolate sodium, and cyclosporine, amongst others. It offers items to greater than 70 nations, together with regulated markets together with the US, Europe, Japan, and India.

The DRHP provides that fermentation is a tough course of because it requires managing a number of course of parameters, working with microbial strains and cultures, and finishing up numerous purification procedures.

 

It has a portfolio of 56 manufacturers and 65 merchandise as of March 31, 2022, comprising 22 APIs and 43 formulations. In addition they provided 80 out-licensed formulations underneath their very own emblems in India. It has submitted over 120 DMFs in numerous nations.

 

One of many few biopharma corporations on this planet which have successfully and sustainably created and expanded its fermentation-based API manufacturing capabilities is the Ahmedabad-based enterprise. There are three manufacturing areas with a mixed put in fermentation capability of 1,250 m3 within the Gujarati state of Valthera, Dholka, and Limbasi.